EUVIMEDEUVIMED entdecken
Crossref

A glucan from Ganoderma lucidum: Structural characterization and the anti-inflammatory effect on Parkinson's disease via regulating dysfunctions of intestinal microecology and inhibiting TLR4/MyD88/NF-κB signaling pathway

Li Chen, Yingjie Ling, Jiaxin Sun, Shuo Zhou, Yao Xiao, Xinyu Zou, Xiudong Yang, Yan Zhang

Journal of Ethnopharmacology · 2025-03 · 343 · 119446

DOI: 10.1016/j.jep.2025.119446 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2025-03. Verfasst von Li Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Jiaxing University, Jiaxing, 314001, PR China; School of Chemical and Pharmaceutical Engineering, Jilin Institute of Chemical Te…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Reishi, Anti-Inflammatory Agents, Glucans. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 76 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGICAL RELEVANCE: Ganoderma lucidum (Curtis) P. Karst (G. lucidum) is a traditional Chinese medicinal fungus, used to exert a beneficial effect on central nervous system, such as Parkinson's disease (PD). Polysaccharide is its main active ingredient, but the structural characterization and the mechanisms of the beneficial effect on PD remain to be elucidated. AIM OF THE STUDY: To obtain a purified G. lucidum polysaccharide and elucidate its structure, investigate the anti-inflammatory effect on PD and explore its potential mechanisms. MATERIALS AND METHODS: The structure of polysaccharide was analyzed through methylation analysis and NMR analysis. The anti-inflammatory effect on PD were explored in a MPTP-induced mouse model. A comprehensive microbiota-gut-metabolomics analysis was executed and subsequently deliberated, focusing on the regulation of dysfunctions of intestinal microecology. The potential mechanisms were investigated using a LPS-induced Caco-2 cell model. RESULTS: A purified glucan, GLPZ-2 was obtained. GLPZ-2 was with triple helical structure and its backbone was found to be primarily composed of 1,6-α-D-Glcp, 1,4-α-D-Glcp, 1,4,6-α-D-Glcp and 1,3,6-β-D-Glcp, with branches at the C-3 and C-4 position by t-α-D-Glcp. PD mice experiments showed that GLPZ-2 could improve motor symptoms, reduce pathological damage and decrease brain protein expression of α-Syn, IL-6, IL-1β and TNF-α. GLPZ-2 also could regulate the gut microbiota and fecal metabolites to restore to normal trend, increase SCFAs content and inhibit TLR4/MyD88/NF-κB pathway in intestine. CONCLUSIONS: GLPZ-2 exhibits an anti-inflammatory effect on PD, which provide a foundational basis for the application of GLPZ-2 as an effective drug to prevent and delay PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeReishiAnti-Inflammatory AgentsGlucansParkinson DiseaseAnimalsHumansNF-kappa BMiceToll-Like Receptor 4Signal TransductionMaleMice, Inbred C57BLMyeloid Differentiation Factor 88Caco-2 CellsDisease Models, Animal

Stichwörter der Autor:innen

Ganoderma lucidum polysaccharideInflammationIntestinal microecologyParkinson's diseaseStructural characterizationTLR4

Substanzen

Anti-Inflammatory AgentsNF-kappa BToll-Like Receptor 4Myeloid Differentiation Factor 88GlucansTlr4 protein, mouseMyd88 protein, mouseTLR4 protein, human

Autor:innen und Institutionen

  • College of Medicine, Jiaxing University, Jiaxing, 314001, PR China; School of Chemical and Pharmaceutical Engineering, Jilin Institute of Chemical Technology, Jilin, 132022, PR China.
  • College of Medicine, Jiaxing University, Jiaxing, 314001, PR China.
  • School of Chemical and Pharmaceutical Engineering, Jilin Institute of Chemical Technology, Jilin, 132022, PR China. Electronic address: yangwt_1981@163.com.
  • College of Medicine, Jiaxing University, Jiaxing, 314001, PR China. Electronic address: zhangyan8119@zjxu.edu.cn.

Zitieren

APA

Chen, L., Ling, Y., Sun, J., Zhou, S., Xiao, Y., Zou, X., Yang, X., & Zhang, Y. (2025). A glucan from Ganoderma lucidum: Structural characterization and the anti-inflammatory effect on Parkinson's disease via regulating dysfunctions of intestinal microecology and inhibiting TLR4/MyD88/NF-κB signaling pathway. Journal of Ethnopharmacology, 343, 119446. https://doi.org/10.1016/j.jep.2025.119446

Vancouver

Chen L, Ling Y, Sun J, Zhou S, Xiao Y, Zou X, et al. A glucan from Ganoderma lucidum: Structural characterization and the anti-inflammatory effect on Parkinson's disease via regulating dysfunctions of intestinal microecology and inhibiting TLR4/MyD88/NF-κB signaling pathway. Journal of Ethnopharmacology. 2025;343:119446. doi:10.1016/j.jep.2025.119446

BibTeX
@article{Chen2025,
  author = {Chen, Li and Ling, Yingjie and Sun, Jiaxin and Zhou, Shuo and Xiao, Yao and Zou, Xinyu and Yang, Xiudong and Zhang, Yan},
  title = {A glucan from Ganoderma lucidum: Structural characterization and the anti-inflammatory effect on Parkinson's disease via regulating dysfunctions of intestinal microecology and inhibiting TLR4/MyD88/NF-κB signaling pathway},
  journal = {Journal of Ethnopharmacology},
  year = {2025},
  volume = {343},
  pages = {119446},
  doi = {10.1016/j.jep.2025.119446}
}
Kostenlos starten →